Evidence map›Paper›PMID 35110631›Full record

ArticleScientific reports2022

Arterial enhancing local tumor progression detection on CT images using convolutional neural network after hepatocellular carcinoma ablation: a preliminary study.

Sanghyeok Lim, YiRang Shin, Young Han Lee

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Sanghyeok Lim *Department of Radiology, Research Institute of Radiological Science, and Center for Clinical Imaging Data Science (CCIDS), Yonsei University College of Medicine, Seoul, Korea.
YiRang Shin *Department of Radiology, Research Institute of Radiological Science, and Center for Clinical Imaging Data Science (CCIDS), Yonsei University College of Medicine, Seoul, Korea.
Young Han LeeDepartment of Radiology, Research Institute of Radiological Science, and Center for Clinical Imaging Data Science (CCIDS), Yonsei University College of Medicine, Seoul, Korea. sando@yuhs.ac.
Yonsei University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To evaluate the performance of a deep convolutional neural network (DCNN) in detecting local tumor progression (LTP) after tumor ablation for hepatocellular carcinoma (HCC) on follow-up arterial phase CT images. The DCNN model utilizes three-dimensional (3D) patches extracted from three-channel CT imaging to detect LTP. We built a pipeline to automatically produce a bounding box localization of pathological regions using a 3D-CNN trained for classification. The performance metrics of the 3D-CNN prediction were analyzed in terms of accuracy, sensitivity, specificity, positive predictive value (PPV), area under the receiver operating characteristic curve (AUC), and average precision. We included 34 patients with 49 LTP lesions and randomly selected 40 patients without LTP. A total of 74 patients were randomly divided into three sets: training (n = 48; LTP: no LTP = 21:27), validation (n = 10; 5:5), and test (n = 16; 8:8). When used with the test set (160 LTP positive patches, 640 LTP negative patches), our proposed 3D-CNN classifier demonstrated an accuracy of 97.59%, sensitivity of 96.88%, specificity of 97.65%, and PPV of 91.18%. The AUC and precision-recall curves showed high average precision values of 0.992 and 0.96, respectively. LTP detection on follow-up CT images after tumor ablation for HCC using a DCNN demonstrated high accuracy and incorporated multichannel registration.

Indexed as

Neural Networks, ComputerAblation TechniquesAgedArteriesCarcinoma, HepatocellularFemaleHumansLiver NeoplasmsMaleMiddle AgedPredictive Value of TestsRadiopharmaceuticalsRetrospective StudiesROC CurveTomography, X-Ray ComputedRadiopharmaceuticals

Identifiers

PMID35110631
PMCPMC8810956
OpenAlexW4210594853

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.